Home › Funds › Royce & Associates › TECH
Royce & Associates position in TECH
BIO-TECHNE CORP · Health Care
Latest position (Q2 2026)789.75K sh
Reported value held$55.80M
Portfolio Weight0.45%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 78.91K | $38.24M | New |
| Q4 2021 | 76.44K | $39.55M | Reduce |
| Q1 2022 | 79.37K | $34.37M | Add |
| Q2 2022 | 95.86K | $33.23M | Add |
| Q3 2022 | 101.50K | $28.82M | Add |
| Q4 2022 | 452.11K | $37.47K | Add |
| Q1 2023 | 695.20K | $51.58K | Add |
| Q2 2023 | 545.64K | $44.54M | Reduce |
| Q3 2023 | 674.28K | $45.90M | Add |
| Q4 2023 | 683.47K | $52.74M | Add |
| Q1 2024 | 796.56K | $56.07M | Add |
| Q2 2024 | 828.10K | $59.33M | Add |
| Q3 2024 | 845.40K | $67.57M | Add |
| Q4 2024 | 860.75K | $62.00M | Add |
| Q1 2025 | 870.18K | $51.02M | Add |
| Q2 2025 | 870.89K | $44.81M | Hold |
| Q3 2025 | 660.03K | $36.72M | Reduce |
| Q4 2025 | 678.50K | $39.90M | Add |
| Q1 2026 | 759.71K | $39.70M | Add |
| Q2 2026 | 789.75K | $55.80M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TECH
- Vanguard Group 17.81M sh · $1.05B · Q4 2025
- BlackRock Inc 14.03M sh · $990.92M · Q2 2026
- Fidelity Management & Research (FMR) 12.79M sh · $903.95M · Q2 2026
- Goldman Sachs Group 7.34M sh · $518.81M · Q2 2026
- Morgan Stanley 6.37M sh · $450.37M · Q2 2026
- Geode Capital Management 5.35M sh · $377.54M · Q2 2026
- Invesco Ltd 4.99M sh · $352.29M · Q2 2026
- Ruane Cunniff & Goldfarb (Sequoia) 3.35M sh · $236.60M · Q2 2026
- MFS Investment Management 2.75M sh · $194.01M · Q2 2026
- Capital Research Global Investors 2.62M sh · $185.24M · Q2 2026
- UBS Group AG 2.48M sh · $175.11M · Q2 2026
- JPMorgan Chase & Co 1.86M sh · $132.60M · Q2 2026